Web Analytics
icon
Buscar en Clarke Modet
Regulatory

Medical devices: technical services

Navigate medical device regulation to accelerate your time to market with safety and compliance. Medical device regulation, including AI, is becoming increasingly stringent to ensure product safety and performance.

What we do for you

Size=XL, Color=Azul, Icono=Entorno, Variante = 09 (1)

MD/MDSW/IVD Classification

We advise you to correctly classify your medical devices (MD, MDSW, IVD), ensuring that they comply with regulatory requirements and facilitating the definition of the appropriate regulatory strategies.

icons-4

Regulatory strategy

Clear and tailor-made roadmap to market and regulatory compliance.

icons-5

Quality system

We implement the quality system according to current regulations.

Size=XL, Color=Azul, Icono=Usuario, Variante=05 (1)

Pre-clinical and clinical consulting

Technical support in development according to local and international regulations.

icons-6

Clinical evaluation

Elaboration of technical and clinical documentation to achieve commercialization.

Size=XL, Color=Azul, Icono=Interfaz, Variante=23 (1)

CE marking application

Analysis of documentation to verify compliance with prerequisites, preparation of the technical dossier (GAP analysis) and submission to the competent regulatory authority.

Vector

Import and export

Global assistance to operate safely and in compliance.

Everything you need, in one place

  • Specific project assessment and strategic accompaniment: identification of steps in the process with structured order.
  • Comprehensive support service, connecting with other key agents in the development and commercialization process.
  • Understanding of international regulatory frameworks that allow acceleration of registrations before previous approvals (Latin America).
  • Experience in software and AI medical devices.

News

Explore our latest news, articles, and events to stay up to date on the trends driving the world of innovation.

Brazil’s Regulatory Transformation: Why Global Life Sciences Companies Should Enter the Brazilian Market Now
Brazil, the largest pharmaceutical market in Latin America, has just removed one of the biggest barriers to entry. Since June 29, 2026, pharmaceutical companies no longer need to have their products registered in another country before applying for registration with ANVISA, the Brazilian health regulatory agency. Combined with a strengthened regulatory reliance framework, this unprecedented […]
Legislative news
Clinical Research & GCP for Brazil and Australia (for USA and European market)
Why Brazil and Australia? Unlocking Opportunities for Diverse and Efficient Clinical Development As sponsors increasingly seek more diverse patient populations, faster recruitment, and efficient regulatory pathways, Brazil and Australia have emerged as two highly attractive destinations for clinical research. Both countries offer unique advantages for global clinical development programs. Brazil provides access to a large, […]
9:00 am San Francisco, PST local time; 12:00 pm New York, EST local time; 5:00 pm Lisbon, London local time; 6:00 pm Madrid, Berlin local time
Online events
Clinical Research & GCP for Brazil and Australia (for APAC market)
Why Brazil and Australia? Unlocking Opportunities for Diverse and Efficient Clinical Development As sponsors increasingly seek more diverse patient populations, faster recruitment, and efficient regulatory pathways, Brazil and Australia have emerged as two highly attractive destinations for clinical research. Both countries offer unique advantages for global clinical development programs. Brazil provides access to a large, […]
09:00 hrs Shanghai local time; 10:00 hrs Tokyo local time; 11:00 hrs Sydney local time
Online events
Go to news